Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-22-035821
Filing Date
2022-10-03
Accepted
2022-10-03 16:50:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 ny20005291x6_424b5.htm 424B5 109108
2 logo_roivant02.jpg GRAPHIC 41282
3 logo_roivant02x1.jpg GRAPHIC 46340
  Complete submission text file 0001140361-22-035821.txt   230436
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-267503 | Film No.: 221288130
SIC: 2834 Pharmaceutical Preparations